Breathlessness, Alcohol, and Opiates

Bar‐Or, David; Marx, JA; Good, Jean Marc

doi:10.1056/nejm198206033062214

Cited by 58 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies evaluating oral morphine: (Woodcock et al 1981c, 1982; Johnson et al 1983; Eiser et al 1991; Light et al 1996; Chua et al 1997; Poole et al 1998)…”

Section: Selected Reference Listmentioning

confidence: 99%

Palliative management of refractory dyspnea in COPD

Uronis¹,

Currow²,

Abernethy³

2006

International Journal of COPD

View full text Add to dashboard Cite

COPD is a progressive illness with worldwide impact. Patients invariably reach a point at which they require palliative interventions. Dyspnea is the most distressing symptom experienced by these patients; when not relieved by traditional COPD management strategies it is termed “refractory dyspnea” and palliative approaches are required. The focus of care shifts from prolonging survival to reducing symptoms, increasing function, and improving quality of life. Numerous pharmacological and non-pharmacological interventions can achieve these goals, though evidence supporting their use is variable. This review provides a summary of the options for the management of refractory dyspnea in COPD, outlining currently available evidence and highlighting areas for further investigation. Topics include oxygen, opioids, psychotropic drugs, inhaled furosemide, Heliox, rehabilitation, nutrition, psychosocial support, breathing techniques, and breathlessness clinics.

show abstract

“…Studies evaluating oral morphine: (Woodcock et al 1981c, 1982; Johnson et al 1983; Eiser et al 1991; Light et al 1996; Chua et al 1997; Poole et al 1998)…”

Section: Selected Reference Listmentioning

confidence: 99%